MAMasaaki Arai

Masaaki Arai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masaaki Arai has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Kunio Takishima

    Department of Biochemistry, National Defense Medical College, Tokorozawa, Saitama, Japan

    2 shared publications
  • Minori Dateki

    Department of Biochemistry, National Defense Medical College, Tokorozawa, Saitama, Japan

    2 shared publications
  • Osamu Imamura

    Department of Biochemistry, National Defense Medical College, Tokorozawa, Saitama, Japan

    2 shared publications
  • Akira Yamagata

    Department of Nephrology and Endocrinology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

    1 shared publication
  • Asako Takagi

    Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

    1 shared publication
  • Hidehito Matsubara

    Department of Nephrology and Rheumatology, Kyorin University School of Medicine, Mitaka, Japan

    1 shared publication

Latest Publications

  • PEPITEM/Cadherin 15 Axis Inhibits T Lymphocyte Infiltration and Glomerulonephritis in a Mouse Model of Systemic Lupus Erythematosus

    by Hidehito Matsubara, Yoshitaka Shimizu, Masaaki Arai, Akira Yamagata, Seigo Ito, Toshihiko Imakiire, Masashi Tsunoda, Hiroo Kumagai, Naoki Oshima

    Control of lymphocyte infiltration in kidney is a potential therapeutic strategy for lupus nephritis, considering that control of lymphocyte migration by sphingosine 1 phosphate has been implicated in inflammation-related pathology. The peptide inhibitor of the transendothelial migration (PEPITEM)/cadherin (CDH) 15 axis was recently reported to promote sphingosine 1 phosphate secretion. In this study, we investigated whether CDH15 is expressed in the kidney of MRL/lpr mice and whether lymphocyte infiltration is suppressed by exogenously administered PEPITEM. Mice (18 wk old) were randomized into 4-wk treatment groups that received PEPITEM or PBS encapsulated in dipalmitoylphosphatidylcholine liposomes. Enlargement of the kidney, spleen, and axillary lymph nodes was suppressed by PEPITEM treatment, which also blocked infiltration of double-negative T lymphocytes into the kidney and glomerular IgG/C3 deposition, reduced proteinuria, and increased podocyte density. Immunohistochemical analysis revealed that the PEPITEM receptor CDH15 was expressed on vascular endothelial cells of glomeruli and kidney arterioles, skin, and peritoneum in lupus mice at 22 wk of age but not in 4-wk-old mice. These results suggest that PEPITEM inhibits lymphocyte migration and infiltration into the kidney, thereby preserving the kidney structure and reducing proteinuria. Thus, PEPITEM administration may be considered as a potential therapeutic tool for systemic lupus erythematosus.


  • Donepezil‐induced oligodendrocyte differentiation is mediated through estrogen receptors

    by Osamu Imamura, Masaaki Arai, Minori Dateki, Kazuhiko Oishi, Kunio Takishima

    Loss of oligodendrocytes, the myelin‐forming cells of the central nervous system, and subsequent failure of myelin development result in serious neurological disorders such as multiple sclerosis. Using primary mouse embryonic neural stem cells (NSCs), we previously demonstrated that donepezil, an acetylcholinesterase inhibitor developed for the treatment of Alzheimer's disease, stimulates the differentiation of NSCs into oligodendrocytes and neurons, albeit at the expense of astrogenesis. However, the precise mechanisms underlying donepezil‐induced differentiation remain unclear. In this study, we aimed at elucidating the molecular pathways contributing to donepezil‐induced differentiation of mouse‐induced pluripotent stem cell‐derived neural stem cells (miPSC‐NSCs). We used cell‐based reporter gene arrays to investigate effects of donepezil on differentiation of miPSC‐NSCs. Subsequently, we assessed the molecular pathway underlying donepezil action on differentiation of miPSC‐NSCs into mature oligodendrocytes. Donepezil increased the transcriptional activity of estrogen response element under differentiating conditions. Moreover, estrogen receptors α (ERα) and β (ERβ) were highly expressed in MBP‐positive mature oligodendrocytes. The ER antagonist ICI 182,780 abrogated the number of MBP‐positive oligodendrocytes induced by donepezil, but showed no effect on the differentiation of miPSC‐NSCs into Tuj1‐positive neurons and GFAP‐positive astrocytes. Furthermore, the donepezil‐induced generation of mature oligodendrocytes from miPSC‐NSC was significantly attenuated by antagonists and siRNA targeting ERα and ERβ. In conclusion, we demonstrated, for the first time, that donepezil‐induced oligodendrogenesis is mediated through both ER subtypes, ERα and ERβ. image Cover Image for this issue: https://doi.org/10.1111/jnc.14771.


  • Neuronal Ca2+‐dependent activator protein 1 (NCDAP1) induces neuronal cell death by activating p53 pathway following traumatic brain injury

    by Masaaki Arai, Osamu Imamura, Nobuo Kondoh, Minori Dateki, Kunio Takishima

    Overactivation of N‐methyl‐D‐aspartate glutamate receptors (NMDARs) after traumatic brain injury (TBI) contributes to excitotoxic cell death. The hyperactivation of NMDARs results in toxic levels of intracellular Ca2+ and in the activation of p53‐mediated apoptosis pathway. Neuronal Ca2+‐dependent activator protein 1 (NCDAP1) was identified as an epileptogenic gene of unknown function in our laboratory. In this study, we investigated the expression and cellular localization of NCDAP1 in rat models of fluid percussion‐induced TBI. NCDAP1 expression increased in the ipsilateral cortex and hippocampus adjacent to the lesion of the TBI rats compared with that in the sham‐operated controls. In addition, NCDAP1 was co‐expressed with neuronal marker (NeuN), and the results of terminal deoxynucleotidyl transferase‐mediated dUTP nick‐end labeling (TUNEL) staining suggest that NCDAP1 is involved in neuronal apoptosis that occurs after brain injury. In addition, the expression levels of p53, Bax, and active caspase‐3 correlated with those of NCDAP1. To further investigate the function of NCDAP1, primary cultured neurons were employed to establish an apoptosis model. The expression of NCDAP1 was induced by NMDA‐induced Ca2+ influx, and the knockdown of NCDAP1 by siRNA decreased apoptosis caused by treatment with NMDA. Silencing of NCDAP1 also reduced p53 expression, whereas the overexpression of NCDAP1 induced cell death and upregulated the expression of p53. The inhibition of p53 with pifithrin alpha or siRNA counteracted the effects of NCDAP1. Based on our data, we suggest that NCDAP1 plays an important role in p53‐mediated neuronal apoptosis following TBI.


  • Open Access

    Resistance to cyclosporin A derives from mutations in hepatitis C virus nonstructural proteins

    by Masaaki Arai, Kyoko Tsukiyama-Kohara, Asako Takagi, Yoshimi Tobita, Kazuaki Inoue, Michinori Kohara


  • Noise Reduction of a Supersonic Jet Using Gas Injection from a Nozzle Wall

    by Mikiya Araki, Kosuke Kuwabara, Masaaki Arai, Tsuneaki Ishima, Seiichi Shiga, Tomio Obokata